Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Sheldon Sloan, the Chief Medical Officer at Spyre Therapeutics, Inc. (NASDAQ:SYRE), executed a comprehensive divestiture of his equity position, selling 8,334 shares for a total of $730,895 on July 1, 2026. The transaction involved the exercise of stock options at $27.46 per share followed by immediate sales at prices ranging from $87.03 to $88.95.…
Spyre Therapeutics CEO Cameron Turtle executed a series of stock sales totaling approximately $1.32 million in early July 2026. The transactions occurred against a backdrop of significant stock appreciation and positive clinical trial updates for the company's ulcerative colitis candidate. Turtle's sales were conducted under a pre-existing trading …
CoreWeave, Inc. (CRWV) Chief Strategy Officer Brian Venturo executed a series of share transactions totaling approximately $12.9 million in late June and early July 2026. The moves include direct sales to cover tax liabilities from restricted stock unit settlements and indirect sales through affiliated entities operating under a pre-arranged 10b5-1…
Kristen J McVeety, serving as General Counsel and Secretary for CoreWeave, Inc. (NASDAQ:CRWV), executed a sale of 4 shares of the company’s Class A Common Stock on June 30, 2026. The transaction, valued at $382, occurred at a price of $95.69 per share. This sale was necessitated by tax withholding obligations linked to the vesting and settlement of…
CoreWeave, Inc. (NASDAQ:CRWV) CEO Michael N. Intrator executed a significant divestment of company equity, offloading approximately $37.7 million in Class A Common Stock on June 30, 2026. This transaction, reported through an SEC Form 4 filing, involves a mix of direct sales and indirect transactions through Omnadora Capital LLC. While a portion of…
CoreWeave EVP Goldberg Chen sold a small portion of his holdings on June 30, 2026, while simultaneously acquiring shares from restricted stock unit settlements. The transaction occurs against a backdrop of significant stock price declines and ongoing strategic developments within the company, including the launch of a new AI research agent and comp…
Sachin Jain, Chief Operating Officer of CoreWeave, Inc. (NASDAQ:CRWV), executed a series of stock transactions on June 30, 2026, selling three shares of Class A Common Stock at $95.69 per share. The sale was processed to cover tax withholding obligations associated with the vesting of restricted stock units. Concurrently, Jain acquired seven shares…
CoreWeave, Inc. (NASDAQ:CRWV) Chief Financial Officer Nitin Agrawal executed a transaction on June 30, 2026, selling four shares of the company's Class A Common Stock. The sale, valued at $382, was conducted to meet tax withholding requirements related to the vesting and settlement of restricted stock units. This transaction occurred as CoreWeave's…
Jeff Baker, CoreWeave's principal accounting officer, executed a minor stock sale on June 30, 2026, to satisfy tax liabilities from vesting restricted stock units. The transaction occurred against a backdrop of significant stock depreciation, with shares falling over 15% in a week and more than 50% year-over-year. Concurrently, the company is manag…
Procore Technologies, Inc. (NASDAQ: PCOR) director Kevin J. O’Connor has executed a series of stock sales totaling $488,902 through a pre-established Rule 10b5-1 trading plan. The transactions, which occurred on July 1 and July 2, 2026, were conducted indirectly via the Kevin J. O’Connor Revocable Trust. This insider activity unfolds against a back…
Immunome Inc. director Isaac Barchas has completed a series of indirect stock sales totaling $4,393,024 across June and July 2026. The transactions, executed through entities ABHMC II LLC and Arsenal Bridge Venture II-B LLC, were structured under pre-established Rule 10b5-1 trading plans adopted in March 2026. While the sales occurred after a signi…
Several major stakeholders in Jewett-Cameron Trading Co Ltd (NASDAQ:JCTC), including AJB Investment Fund II, LP, AJB Capital, LLC, Adam James Bradley, and Melinda Hodges Bradley, have collectively purchased $25,871 worth of company stock. The acquisition of 11,009 shares occurred on July 1, 2026, at a price of $2.35 per share. This strategic buying…
Matthew David Feierstein, president of EverCommerce Inc. (NASDAQ: EVCM), completed three separate sales of company stock between June 30 and July 2, 2026, totaling approximately $259,556. The transactions, executed under a Rule 10b5-1 plan established in August 2025, reduced his direct shareholding to 2,055,448 shares. The sales occur as EverCommer…
Edward Smolyansky, a significant 10% shareholder in Lifeway Foods, Inc. (NASDAQ:LWAY), executed a series of stock sales totaling approximately $5.18 million during the final days of June. The transactions occurred while the company's shares were trading near their 52-week highs, reflecting a period of substantial price appreciation. Despite the ins…
EverCommerce Inc. (NASDAQ: EVCM) Chief Executive Officer Eric Richard Remer recently divested a portion of his equity holdings through two separate transactions executed under a Rule 10b5-1 trading plan. The sales, totaling approximately $331,150, occurred over June 30 and July 1, 2026, at varying price points. Following these dispositions, Mr. Rem…
Scott Daniel Forney, General Counsel of MarketWise, Inc. (NASDAQ: MKTW), executed a share withholding transaction on July 1, 2026, to cover tax liabilities associated with the vesting of restricted stock units. The issuer withheld 711 shares at a price of $19.14 each, totaling $13,608. This administrative action does not constitute a sale by Forney…
Marco Galsim, Chief Information Officer at MarketWise, Inc. (NASDAQ: MKTW), executed a disposition of 3,294 shares of the company's Class A Common Stock on July 1, 2026. The transaction, valued at $19.14 per share for a total of $63,047, was facilitated through shares withheld to meet tax withholding and remittance obligations linked to the vesting…
Erik Mickels, Chief Financial Officer of MarketWise, Inc. (NASDAQ:MKTW), experienced a mandatory stock withholding event to satisfy tax obligations arising from the vesting of restricted stock units. The transaction involved 3,973 shares withheld at $19.14 per share, totaling $76,043. Following the withholding, Mr. Mickels retains direct ownership …
Abhinav Shukla, Chief Technical Officer at Shattuck Labs, Inc. (NASDAQ:STTK), executed two stock transactions totaling approximately $166,131 on June 30 and July 1, 2026. The sales, facilitated through a Rule 10b5-1 trading plan established in February 2026, were structured to cover the exercise price and estimated tax withholding for stock options…
Neil Blumenthal, co-CEO of Warby Parker Inc. (NYSE: WRBY), executed a significant divestiture of Class A Common Stock valued at approximately $6.4 million on July 1, 2026. The transaction involved the sale of 217,667 shares at an average price of $29.61, conducted under a pre-arranged Rule 10b5-1 trading plan established in March 2026. This sale co…
Warby Parker Inc. (NYSE:WRBY) co-CEO David Abraham Gilboa executed a significant stock sale on July 1, 2026, disposing of Class A Common Stock worth $7,191,541 under a Rule 10b5-1 trading plan adopted in March of that year. The transaction occurred as WRBY shares approached a 52-week high of $31, reflecting a 34% year-to-date gain. Concurrently, Gi…
CrowdStrike Holdings Inc. Chief Executive Officer George Kurtz executed a series of stock sales totaling approximately $1.94 million on July 1, 2026. The dispositions were carried out under the guidelines of a pre-arranged Rule 10b5-1 trading plan established in January 2026. These transactions occurred as CrowdStrike's equity experienced significa…
Shattuck Labs, Inc. (NASDAQ: STTK) has reported a significant insider transaction involving its Chief Medical Officer, Arundathy Pandite. On June 30, 2026, Pandite sold 30,000 shares of the company's common stock, generating a total transaction value of $210,300. The sale, executed under a Rule 10b5-1 trading plan established earlier in the year, o…
Jennifer F. Scanlon, President and CEO of UL Solutions Inc. (NASDAQ:ULS), sold a total of 12,500 shares of the company’s Class A Common Stock on July 1, 2026. The transactions amounted to a total value of $1,240,276. These sales were executed pursuant to a Rule 10b5-1 trading plan, which Ms. Scanlon adopted on December 9, 2025. The shares were sold…
Omada Health, Inc. (NASDAQ:OMDA) Chief Financial Officer Steven L. Cook executed a transaction involving the sale of company stock, according to a Form 4 filing. The sale occurred on June 30, 2026, and was part of a pre-arranged 10b5-1 trading plan adopted in March 2026. This activity comes as the company reports strong first-quarter financial resu…
